{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:30:12Z","timestamp":1789810212576,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210991","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T15:50:08Z","timestamp":1548258608000},"page":"e0210991","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":58,"title":["Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1634-1988","authenticated-orcid":true,"given":"Olivier","family":"Ballo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikram","family":"Tarazzit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-6622","authenticated-orcid":true,"given":"Jan","family":"Stratmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Reinheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hogardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wichelhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkhard","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Finkelmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brandts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"issue":"14","key":"ref1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia","volume":"341","author":"B Lowenberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2007-06-095844","article-title":"Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia","volume":"110","author":"E Atallah","year":"2007","journal-title":"Blood"},{"issue":"32","key":"ref3","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1200\/JCO.2008.20.6490","article-title":"Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10","volume":"27","author":"F Mandelli","year":"2009","journal-title":"J Clin Oncol"},{"issue":"13","key":"ref4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMoa0904544","article-title":"Anthracycline dose intensification in acute myeloid leukemia","volume":"361","author":"HF Fernandez","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","article-title":"Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"92","author":"S Neumann","year":"2013","journal-title":"Ann Hematol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s15010-007-6316-4","article-title":"Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay","volume":"36","author":"AM Sostarich","year":"2008","journal-title":"Infection"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"AP Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/nyas.12537","article-title":"Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management","volume":"1323","author":"E Temkin","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1128\/JCM.02117-12","article-title":"Laboratory detection of Enterobacteriaceae that produce carbapenemases","volume":"50","author":"D Doyle","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/dkp428","article-title":"Global spread of carbapenem-resistant Acinetobacter baumannii","volume":"65","author":"PG Higgins","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"1 Suppl 2","key":"ref11","first-page":"25","article-title":"A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia","volume":"16","author":"PH Wiernik","year":"1989","journal-title":"Semin Oncol"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V69.3.744.744","article-title":"High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia","volume":"69","author":"W Hiddemann","year":"1987","journal-title":"Blood"},{"issue":"51\u201352","key":"ref13","first-page":"863","article-title":"The treatment of elderly patients with acute myeloid leukemia","volume":"108","author":"U Krug","year":"2011","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00277-017-3196-2","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)","volume":"97","author":"SC Mellinghoff","year":"2018","journal-title":"Ann Hematol"},{"key":"ref15"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america","volume":"52","author":"AG Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"H Dohner","year":"2010","journal-title":"Blood"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"e35780","DOI":"10.1371\/journal.pone.0035780","article-title":"Molecular analysis and risk factors for Escherichia coli producing extended-spectrum beta-lactamase bloodstream infection in hematological malignancies","volume":"7","author":"P Cornejo-Juarez","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","article-title":"Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey","volume":"91","author":"EM Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/jac\/dku305","article-title":"A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies","volume":"69","author":"MJ Vehreschild","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12879-017-2297-9","article-title":"Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias","volume":"17","author":"A Micozzi","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","article-title":"Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes","volume":"66","author":"C Gudiol","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1007\/s00520-014-2582-8","article-title":"Risk factors for piperacillin\/tazobactam-resistant Gram-negative infection in hematology\/oncology patients with febrile neutropenia","volume":"23","author":"BL Marini","year":"2015","journal-title":"Support Care Cancer"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/ice.2014.3","article-title":"Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia","volume":"36","author":"CD Ford","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2016.11.009","article-title":"Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008\u20132013","volume":"49","author":"CY Chen","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2017.05.016","article-title":"Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study","volume":"23","author":"S Scheich","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"e2018025","DOI":"10.4084\/mjhid.2018.025","article-title":"Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study","volume":"10","author":"SR Jaiswal","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/cid\/ciu052","article-title":"The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies","volume":"58","author":"MJ Satlin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s15010-012-0269-y","article-title":"Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies","volume":"40","author":"BJ Liss","year":"2012","journal-title":"Infection"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1469-0691.2011.03606.x","article-title":"The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study","volume":"18","author":"DC Lye","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"C Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00520-010-0928-4","article-title":"Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia","volume":"19","author":"S Ahn","year":"2011","journal-title":"Support Care Cancer"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00520-014-2454-2","article-title":"C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms","volume":"23","author":"JF Combariza","year":"2015","journal-title":"Support Care Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"14554","DOI":"10.1038\/srep14554","article-title":"Local bacteria affect the efficacy of chemotherapeutic drugs","volume":"5","author":"P Lehouritis","year":"2015","journal-title":"Sci Rep"},{"issue":"6161","key":"ref35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"S Viaud","year":"2013","journal-title":"Science"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:01:57Z","timestamp":1588964517000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210991"}},"subtitle":[],"editor":[{"given":"Senthilnathan","family":"Palaniyandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210991","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]}}}